Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03552926
Other study ID # P150602
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 6, 2018
Est. completion date August 30, 2027

Study information

Verified date April 2022
Source Assistance Publique - Hôpitaux de Paris
Contact Eric JOUVENT, MD, PhD
Phone 33 1 49 95 65 29
Email eric.jouvent@aphp.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this study is to determine in patients with a recent lacunar strokes (<15 days), the natural history of cognitive disturbances and disability.


Description:

This bi-centric cohort study aims at determining in patients with recent lacunar strokes (<15 days), the main clinical, radiological, or genetic predictive markers of recurrent stroke, cognitive impairment, dementia, depression gait disturbances and disability.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date August 30, 2027
Est. primary completion date August 30, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 years and above - History of recent (less than 15 days) neurological deficit related to a small subcortical infarct (evidenced by medical history or physical examination) - Diagnosis of recent small subcortical infarct on MRI (hyperintensity on diffusion-weighted imaging showing an infarction in the territory of one perforating artery) presumably responsible for the corresponding neurological deficit - Lesion diameter mess than 20 mm - Ability to comply with scheduled follow-up and annual neurological evaluation - Affiliation to the national French health insurance (sécurité sociale) - Signature of informed consent Exclusion Criteria: - Prior diagnosis of dementia according to DSM IV criteria - Prior severe disability with Rankin scale = 4 - Serious concomitant systemic disorder that can compromise the follow-up study; - Leukoencephalopathy of non-vascular origin; - Severe psychiatric disorder; - Inability to obtain an informed signed consent from the patient or his/her family; - Medical contraindication or refusal to undergo cerebral magnetic resonance scanning (MRI).

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Hôpital Lariboisière Paris

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to the occurrence of cognitive decline diagnosis of mild or major neurocognitive disorder according to DSM5 5 years
Secondary Recurrent stroke Time to the occurrence of one of the following event 5 years
Secondary Dementia diagnosis of major neurocognitive disorder (dementia) according to DSMV criteria 5 years
Secondary Transient ischaemic attacks " Transient ischemic attack " is a well recognized outcome in clinical trials in neurovascular disorders. We chose the most commonly definition of TIA according to international guidelinesorigin, without recent ischemic lesion on diffusion weighted imaging 5 years
Secondary Cardiovascular events myocardial infarction or cardiac failure 5 years
Secondary Attacks of migraine with aura according to international classification of headache disorders 2nd edition (ICHD-2) 5 years
Secondary Memory complaints any spontaneous complain of memory deficit, irrespective of the neuropsychological battery results 5 years
Secondary Depression or other mood alterations " HADS refers to Hamilton Anxiety and Depression Scale, as stated initially in the title. The scale comprises 14 questions with structured answers ranging from 0 to 3, leading to 2 scores (1 for anxiety, 1 for depression, ranging each from 0 to 21). In each case, larger values are considered to represent worse outcomes. Scores larger or equal to 11 correspond to thresholds to define anxiety and depression " 5 years
Secondary Behavioural disorders according to DSMV classification 5 years
Secondary Balance disturbances according to the SPPB battery 5 years
Secondary Falls according to patient's relatives recording 5 years
Secondary Urinary complaints any spontaneous complain from the patients and/or his relative 5 years